-
Posted by
Two Blokes Mon at 11:30 PM -
Filed in
Stock
-
2 views
Aquestive Therapeutics (AQST) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.17 per share a year ago.
